日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting ENO1 reprograms macrophage polarization to trigger antitumor immunity and improves the therapeutic effect of radiotherapy.

靶向 ENO1 可重编程巨噬细胞极化，从而触发抗肿瘤免疫，并提高放射疗法的治疗效果。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-026-08416-7
Lin Yu-Sen, Chang Hsin-Yu, Hong Wei-Ze, Chen Jhen-Yu, Huang Wei-Ching, Yuan Ta-Tung, Ke Tao-Wei, Tsai Yuan-Yao, Chen Te-Hong, Liang Ji-An, Chao Jui-I, Chao K S Clifford, Huang Kevin Chih-Yang
细胞生物学
巨噬细胞
肿瘤免疫
巨噬细胞
发表日期：2026
文献求助 收藏

Loss of MicroRNA-29b promotes DNMT3b-mediated STING downregulation to attenuate radiotherapy-induced antitumor immunity in KRAS-mutated colorectal cancer.

MicroRNA-29b 的缺失促进 DNMT3b 介导的 STING 下调，从而减弱 KRAS 突变型结直肠癌中放射治疗诱导的抗肿瘤免疫。

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-026-01290-8
Chang Hsin-Yu, Chen Jhen-Yu, Ke Tao-Wei, Jiang Yi-Wen, Hong Wei-Ze, Tsai Yuan-Yao, Chiang Shu-Fen, Lin Yu-Sen, Huang Chi-Hsien, Chen Te-Hong, Chao K S Clifford, Huang Kevin Chih-Yang
肿瘤
肠癌
肿瘤免疫
STING
RAS
免疫/内分泌
发表日期：2026
文献求助 收藏

Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy

免疫检查点抑制剂治疗肝移植后复发性肝细胞癌：免疫抑制保留策略下的安全性

期刊:Annals of Transplantation
影响因子:1.4
doi:10.12659/AOT.952135
Hsu, Shih-Chao; Chen, Sheng-Hsien; Chen, Te-Hong; Hsu, Wei-Fan; Wang, Hung-Wei; Yeh, Chun-Chieh; Yang, Horng-Ren; Lai, Hsueh-Chou; Jeng, Long-Bin
Checkpoint
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy.

靶向 B7-H3 可增强基于新抗原的癌症疫苗与放射疗法联合应用的疗效

期刊:NPJ Vaccines
影响因子:6.5
doi:10.1038/s41541-025-01132-x
Ke Tao-Wei, Chen Chia-Yi, Chen William Tzu-Liang, Tsai Yuan-Yao, Chiang Shu-Fen, Huang Chi-Hsien, Lin Yu-Sen, Chen Te-Hong, Chen Tsung-Wei, Liang Ji-An, Chao K S Clifford, Huang Kevin Chih-Yang
肿瘤
H3
发表日期：2025
文献求助 收藏